Drugs / Gynevac
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02173184 | Jun 2014 → Apr 2015 | bacterial vaginosis | Amvac Kft. | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gynevac | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02173184 ↗ |
| Modality | Vaccine | “a vaccine containing Lactobacillus strains 15, 34, 79, 84, 127 inactivated by formaldehyde” NCT02173184 ↗ |
| Route | Intramuscular | “1 IM injection of Gynevac per week” NCT02173184 ↗ |